The alteration of cirluating EPCs in non-ST elevation acute coronary syndrome

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900026243

Enrollment

Unknown

Registered

2019-09-28

Start date

2019-09-28

Completion date

Unknown

Last updated

2019-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary artery disease

Interventions

low risk group:N/A

middle risk group:N/A

high risk group:N/A

healthy control group:N/A

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. 60 cases of coronary heart disease diagnosed at 25-75 years old, regardless of gender. 2. Non-ST-segment elevation myocardial infarction or unstable angina.

Exclusion criteria

Exclusion criteria: 1. With a history of cerebral infarction or gastrointestinal bleeding within 6 months. 2. Severe infection; 3. Cardiomyopathy, pulmonary heart disease, valvular heart disease; 4. Those who participated in other clinical trials in the last 3 months; 5. Allergies or allergies to known ingredients of the test drug.

Design outcomes

Primary

Measure	Time frame
activity of endothelial progenitor cell;	—

Countries

China

Contacts

Public ContactBin Zhang

Jiangmen Central Hospital

docbinzhang@163.com+86 15307501656

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026